Article Information
History
- May 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Kei Miyakawa1,
- Sundararaj Stanleyraj Jeremiah1,
- Hideaki Kato2,
- Yutaro Yamaoka1,3,
- Hirofumi Go4,
- Takeharu Yamanaka4,5 and
- Akihide Ryo1,*
- 1Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan
- 2Infection Prevention and Control Department, Yokohama City University Hospital, Yokohama, Japan
- 3Life Science Laboratory, Technology and Development Division, Kanto Chemical Co, Inc., Isehara, Japan
- 4Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan
- 5Department of Health Data Science, Yokohama City University Graduate School of Data Science, Yokohama, Japan
- ↵*Corresponding author and address:
Akihide Ryo, M.D., Ph.D, Department of Microbiology and Molecular Biodefense Research, School of Medicine, Yokohama City University, 3-9, Fukuura, Kanazawa, Yokohama, Japan, 236-0004. e-mail: aryo{at}yokohama-cu.ac.jp, Phone: +81-045-787-2602, Fax: +81-045-787-2851
Posted May 10, 2021.
Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
